Icecure Cash Conversion Cycle from 2010 to 2024

ICCM Stock  USD 0.83  0.04  5.06%   
Icecure Medical Cash Conversion Cycle yearly trend continues to be very stable with very little volatility. Cash Conversion Cycle is likely to grow to 364.48 this year. During the period from 2010 to 2024, Icecure Medical Cash Conversion Cycle quarterly data regression pattern had sample variance of  17,671 and median of  117.26. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
347.12503859
Current Value
364.48
Quarterly Volatility
132.93246968
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Icecure Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icecure Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 339.1 K, Interest Expense of 120.2 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 14.37, Dividend Yield of 0.0 or PTB Ratio of 4.22. Icecure financial statements analysis is a perfect complement when working with Icecure Medical Valuation or Volatility modules.
  
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Latest Icecure Medical's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Icecure Medical over the last few years. It is Icecure Medical's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icecure Medical's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

Icecure Cash Conversion Cycle Regression Statistics

Arithmetic Mean183.11
Geometric Mean150.23
Coefficient Of Variation72.60
Mean Deviation102.56
Median117.26
Standard Deviation132.93
Sample Variance17,671
Range434
R-Value0.77
Mean Square Error7,870
R-Squared0.59
Significance0.0009
Slope22.76
Total Sum of Squares247,395

Icecure Cash Conversion Cycle History

2024 364.48
2023 347.13
2022 520.25
2021 269.76
2020 142.01
2019 98.46
2018 117.26

About Icecure Medical Financial Statements

Icecure Medical investors utilize fundamental indicators, such as Cash Conversion Cycle, to predict how Icecure Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle 347.13  364.48 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.079
Return On Assets
(0.47)
Return On Equity
(0.94)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.